Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ404,54050,25
KB492,5494,5-0,20
PKN61,1661,221,10
Msft-0,92
Nokia2,7542,77150,20
IBM-3,33
Daimler AG24,3424,36-2,60
PFE2,34
04.04.2020 1:38:45
Indexy online
AD Index online
select
AD Index online
 

  • 03.04.2020
Richter Gedeon (Budapest)
Závěr k 3.4.2020 Změna (%) Změna (HUF) Objem obchodů (HUF)
6 085,00 -2,01 -125,00 2 287 172 115
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 04.04.2020
Popis společnosti
Obecné informace
Název společnostiRichter Gedeon Vegyeszeti Gyar Nyrt
TickerRICHTER
Kmenové akcie:Ordinary Shares
Kmenové akcie:Ordinary Shares
RICGDRB.BU
ISINHU0000123096
Poslední známé roční výsledky31.12.2019
Poslední známé čtvrtletní výsledky31.12.2019
Počet zaměstnanců k 30.09.2019 12 973
Akcie v oběhu k 31.12.2019 185 700 395
MěnaHUF
Kontaktní informace
UliceGyomroi ut 19-21.
MěstoBUDAPEST
PSČ1103
ZeměHungary
Kontatní osoba 
Funkce kontaktní osoby 
Telefon3 614 314 027
Fax3612604891

Business Summary: Richter Gedeon Vegyeszeti Gyar Nyrt is a Hungary-based company engaged in the research, development, production and marketing and trade of pharmaceutical products. The Company’s business is structured into three segments: the Pharmaceuticals segment, which includes the companies that are involved in the Company’s core business, including research, development and production of pharmaceutical products; the Wholesale and retail segment covers distribution companies and pharmacies that are part of the sales network in various regional markets and, as such convey its products to consumers, and the Other segment presents all the other consolidated companies that provide marketing and sales support services. The Company’s subsidiaries include, among others, Gedeon Richter Romania SA, Gedeon Richter Polska Sp Z.o.o., and ZAO Gedeon Richter-RUS.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2019, Richter Gedeon Vegyeszeti Gyar Nyrt revenues increased 14% to HUF507.79B. Net income increased 39% to HUF49.3B. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Realized Gain/Loss on Derivative-Hedging increase from HUF316M to HUF8.93B (income).
Odvětvová klasifikace
TRBC2012Generic Pharmaceuticals
RBSS2004Pharmaceuticals - Diversified
MGINDUSTRYBiotechnology & Drugs
MGSECTORHealthcare
NAICSPharmaceutical Preparation Manufacturing
NAICSDrug, Drug Proprietaries and Druggists' Sundries Wholesalers
NAICSPharmacies and Drug Stores
SICPharmaceutical Preparations
SICDrugs/proprietaries/sundries
SICDrug Stores/proprietary Stores



  • Poslední aktualizace: 04.04.2020
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chairman of the Board of Directors, Member of the Executive BoardErik Bogsch7201.11.2017
Independent Chairman of the Supervisory BoardAttila Chikan7601.01.2000
Chief Executive Officer, Member of the Executive Board, Member of the Board of DirectorsGabor Orban4101.11.201701.11.2017
Member of the Executive Board, Development DirectorGyorgy Thaler60
Member of the Executive Board, Deputy Managing Director - Finance, Member of the Board of DirectorsGabor Gulacsi62
Member of the Executive Board, Commercial DirectorTibor Horvath45
Member of the Executive Board, Research DirectorIstvan Greiner59